Peramivir (rapivab 200mg/20ml (10mg/Ml INJ Soln))
Contract Overview
Contract Amount: $13,877,674 ($13.9M)
Contractor: Biocryst Pharmaceuticals Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2024-09-30
End Date: 2025-09-29
Contract Duration: 364 days
Daily Burn Rate: $38.1K/day
Official Description: PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))
Place of Performance
Location: North Carolina, 27703